2023 Form 5500 filing — Oyster Point Pharma, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011135119NAL0012557779002) for Oyster Point Pharma, Inc. 401(K) Plan, reported by Oyster Point Pharma, Inc. under EIN 81-1030955 and plan number 001. It reports 297 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241011135119NAL0012557779002
Filing year
2023
Form type
2
Plan sponsor
Oyster Point Pharma, Inc.
EIN
81-1030955
Plan number
001
Location
Princeton, NJ
Participants
297
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$16,928,588
Net assets (EOY)
$16,928,588
Employer contributions
$1,598,165
Participant contributions
$3,693,772
Total income / additions
$9,100,179
Benefits paid
$1,696,596
Administrative expenses
$105,977
Total expenses
$1,802,573
Net increase / (decrease)
$7,297,606
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
T. Rowe Price Retirement Plan SvcsRECORDKEEPER$105,977$0
T. Rowe Price Retirement Plan SvcsRECORDKEEPER$15,289$0

Related Form 5500 pages